Cinacalcet Hcl
Rank #302 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$37.9M
Total Cost
76,761
Total Claims
$37.9M
Total Cost
2,920
Prescribers
$493
Cost per Claim
6,424
Beneficiaries
118,668
30-Day Fills
$13K
Avg Cost/Provider
26
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$37.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $37.9M total
🔎 Data Overview
Average cost of $5,897 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Cinacalcet Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Rafael Khaim | Nurse Practitioner | New York, NY | 296 | $286K |
| 2 | Mita Shah | Nephrology | San Diego, CA | 255 | $277K |
| 3 | Robert Naraghi | Urology | Los Angeles, CA | 265 | $234K |
| 4 | Adrian Whelan | Nephrology | San Francisco, CA | 104 | $230K |
| 5 | Amr Nayel | Family Practice | Astoria, NY | 71 | $200K |
| 6 | Erica Kalu | Nurse Practitioner | Dallas, TX | 200 | $199K |
| 7 | Suzanne Rizkalla | Internal Medicine | Loma Linda, CA | 111 | $176K |
| 8 | Pradeep Kumar Vaitla | Nephrology | Jackson, MS | 267 | $164K |
| 9 | Vasil Peev | Nephrology | Chicago, IL | 177 | $161K |
| 10 | Veronica Delaney | Nephrology | New York, NY | 147 | $143K |
| 11 | Sapna Shah | Nephrology | Los Angeles, CA | 136 | $143K |
| 12 | Cindy Pynadath | Nephrology | Bronx, NY | 126 | $136K |
| 13 | Choli Hartono | Nephrology | Hackensack, NJ | 82 | $126K |
| 14 | Abdul Abdellatif | Nephrology | Webster, TX | 85 | $125K |
| 15 | Mary Shearer | Nurse Practitioner | Lexington, SC | 190 | $122K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 299 | Icatibant Acetate (Icatibant) | $38.4M | 831 |
| 300 | Dextroamphetamine/Amphetamine (Dextroamphetamine-Amphetamine) | $38.2M | 706,329 |
| 301 | Nebivolol Hcl (Nebivolol Hcl) | $38.2M | 421,756 |
| 302 | Cinacalcet Hcl (Cinacalcet Hcl) | $37.9M | 76,761 |
| 303 | Risperidone (Risperidone) | $37.4M | 1,480,207 |
| 304 | Prednisone (Prednisone) | $37.3M | 5,970,737 |
| 305 | Tacrolimus (Tacrolimus) | $37.1M | 175,053 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology